Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells

Blood

Volumn 94, Issue 3, 1999, Pages 959-967

  Outinen, P Andrew ^a   Sood, Sudesh K ^a   Pfeifer, Sabine I ^a   Pamidi, Sushmita ^a   Podor, Thomas J ^a   Li, Jun ^a   Weitz, Jeffrey I ^a   Austin, Richard C ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; COMPLEMENTARY DNA; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; MESSENGER RNA; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; DNA SYNTHESIS; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0345535616     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.3.959.415k20_959_967     Document Type: Article

References (72)

1. Ueland PM, Refsum H, Brattstrom L: Plasma homocysteine and cardiovascular disease, in Francis RB Jr (ed): Atherosclerotic Cardiovascular Disease, Hemostasis and Endothelial Function. New York, NY, Dekker, 1993, p 183
2. Kang S-S, Wong PWK, Malinow MR: Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 12:279, 1992
3. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH: Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 332:286, 1995
4. Mayer EL, Jacobsen DW, Robinson K: Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 27:517, 1996
5. McCully KS: Homocysteine and vascular disease. Nature Med 2:386, 1996
6. D'Angelo A, Selhub J: Homocysteine and thrombotic disease. Blood 90:1, 1997
7. Engbersen AMT, Franken DG, Boers GHJ, Stevens EMB, Trijbels FJM, Blom HJ: Thermolabile 5,10-methylene tetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 56:142, 1995
8. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJM, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R: A candidate risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nature Genet 10:111, 1995
9. Harker LA, Slichter SJ, Scott CR, Ross R: Homocysteinemia: Vascular injury and arterial thrombosis. N Engl J Med 291:537, 1974
10. Harker LA, Harlan JM, Ross R: Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. Circ Res 53:731, 1983
11. Hladovec J: Experimental homocysteinemia, endothelial lesions and thrombosis. Blood Vessels 16:202, 1979
12. Wall RT, Harlan JM, Harker LA, Striker GE: Homocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injury. Thromb Res 18:113, 1980
13. Starkebaum G, Harlan JM: Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 77:1370, 1986
14. de Groot PG, Willems C, Boers GHJ, Gonsalves MD, VanAken WG, Mourik JA: Endothelial cell dysfunction in homocystinuria. Eur J Clin Invest 13:405, 1983
15. Dudman NPB., Hicks C, Wang J, Wilcken DEL: Human arterial endothelial cell detachment in vitro: Its promotion by homocysteine and cysteine. Atherosclerosis 91:77, 1991
16. Rodgers GM, Kane, WH: Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 77:1909, 1986
17. Rodgers GM, Conn MT: Homocysteine, an atherogenie stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 75:895, 1990
18. Lentz SR, Sadler JE: Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 88:1906, 1991
19. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers, GM: Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb 13:1327, 1993
20. Hajjar KA, Mauri L, Jacovina AT, Zhong F, Mirza UA, Padovan JC, Chait BT: Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine. J Biol Chem 273: 9987, 1998
21. Stamler, JS, Osborne JA, Jaraki O, Rabbini LE, Mullins M, Singel S, Loscalzo J: Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91:308, 1993
22. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Heistad DD: Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest 98:24, 1996
23. Rolland PH, Friggi A, BarlatierA, Piquet P, Latrille V, Faye MM, Guillou J, Charpiot P, Bodard H, Ghiringhelli O, Calaf R, Luccioni R, Garcon D: Hyperhomocysteinemia-induced vascular damage in the mini-pig. Circulation 91:1161, 1995
24. Kokame K, Kato H, Miyata T: Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis: GRP78 and novel genes. J Biol Chem 271:29659, 1996
25. Miyata T, Kokame K, Agarwala KL, Kato H: Analysis of gene expression in homocysteine-injured vascular endothelial cells: Demonstration of GRP78/BiP expression, cloning and characterization of a novel reducing agent-tunicamycin regulated gene. Semin Thromb Hemost 24:285, 1998
26. Outinen PA, Sood SK, Liaw PCY, Sarge KD, Maeda N, Hirsh J, Ribau J, Podor TJ, Weitz JI, Austin RC: Characterization of the stress-inducing effects of homocysteine. Biochem J 332:213, 1998
27. Lee AS: Mammalian stress response: induction of the glucose-regulated protein family. Curr Opin Cell Biol 4:267, 1992
28. Lentz SR, Sadler JE: Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum. Blood 81:683, 1993
29. Tsai J, Perrella CMA, Yoshizumi M, Hseih CM, Haber E, Schlegel R, Lee ME: Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc Natl Acad Sci USA 91:6369, 1994
30. Jaffe, EA, Nachmann RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria. J Clin Invest 52:2745, 1973
31. Gething, M-J, McCammon K, Sambrook J: Expression of wild-type and mutant forms of influenza hemagglutinin: The role of folding in intracellular transport. Cell 46:939, 1986
32. Bole DG, Hendershot LM, Keaney JF: Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas. J Cell Biol 102:1558, 1986
33. Navarro D, Qadri I, Pereira L: A mutation in the ectodomain of herpes simplex virus 1 glycoprotein B causes defective processing and retention in the endoplasmic reticulum. Virology 184:253, 1991
34. Ramsay G: DNA chips: State-of-the art. Nature Biotech 16:40, 1998
35. Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, Woolley DE, Davis RW: Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA 94:2150, 1997
36. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM: Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genet 14:457, 1996
37. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RO: Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 93:10614, 1996
38. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL: Expression monitoring by hybridization to high-density oligonucleotide arrays. Nature Biotech 14:1675, 1996
39. Cabibbo A, Consalez GG, Sardella M, Sitia R, Rubartelli A: Changes in gene expression during the growth arrest of HepG2 hepatoma cells induced by reducing agents or TGFß1. Oncogene 16:2935, 1998
40. Wang X-Z, Lawson B, Brewer JW, Zinszner H, Sanjay A, Mi L-J, Boorstein R, Kreibich G, Hendershot LM, Ron D: Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153). Mol Cell Biol 16:4273, 1996
41. Hultberg B, Andersson A, Isaksson A: Metabolism of homocysteine, its relation to the other cellular thiols and its mechanism of cell damage in a cell culture line (human histiocytic cell line U-937). Biochim Biophys Acta 1269:6, 1995
42. Ron D, Habener JF: CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant negative inhibitor of gene transcription. Genes Dev 6:439, 1992
43. Fornace AJ, Nebert DW, Hollander C, Luethy JD, Papathanasiou M, Fargnoli J, Holbrook NJ: Mammalian genes coordinately regulated by growth arrest signals and DMA-damaging agents. Mol Cell Biol 9:4196, 1989
44. Luethy JD, Holbrook NJ: Activation of the gadd153 promoter by genotoxic agents: a rapid and specific response to DNA damage. Cancer Res 52:5, 1992
45. Luethy JD, Fargnoli, J, Park JS, Fornace AJ, Holbrook NJ: Isolation and characterization of the hamster gadd153 gene. J Biol Chem 265:16521, 1990
46. Price BD, Calderwood SK: Gadd45 and Gadd153 messenger RNA levels are increased during hypoxia and after exposure of cells to agents which elevate the levels of the glucose-regulated proteins. Cancer Res 52:3814, 1992
47. Halleck MM, Liu H, North J, Stevens JL: Reduction of trans-4,5-dihydroxy-1,2-dithiane by cellular oxidoreductases activates gadd153/chop and grp78 transcription and induces cellular tolerance in kidney epithelial cells. J Biol Chem 272:21760, 1997
48. Zhan Q, Lord KA, Alamo I Jr, Hollander MC, Carrier F, Ron D, Kohn KW, Hoffman B, Liebermann DA, Fornace AJ Jr: The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol 14:2361, 1994
49. Barone MV, Crozat AY, Tabaee A, Philipson L, Ron D: CHOP (GADD153) and its oncogenic variant, TLS-CHOP, differ in their ability to induce G1/S arrest. Genes Dev 8:453, 1994
50. Crozat AY, Aman P, Mandahl N, Ron D: Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma with t(12;16)(q13;p11). Nature 363:640, 1993
51. Tsujimoto A, Nyunoya H, Morita T, Sato T, Shimotohno K: Isolation of cDNAs for DNA-binding proteins which specifically bind to a tax-responsive enhancer element in the long terminal repeat of human T-cell leukemia virus type I. J Virol 65:1420. 1991
52. Estes SD, Stoler DL, Andersen GR: Normal fibroblasts induce the C/EBP beta and ATF-4 bZIP transcription factors in response to anoxia. Exp Cell Res 220:47, 1995
53. 2+ depletion and formation of aberrant proteins: Activation of the conserved stress-inducible grp core promoter element by the human nuclear factor YY1. Mol Cell Biol 17:54, 1997
54. Austen M, Cerni C, Henriksson M, Hilfenhaus S, Luscher-Firzlaff JM, Menkel A, Seelos C, Sommer A, Luscher B: Regulation of cell growth by the Myc-Max-Mad network: Role of Mad proteins and YY1. Curr Top Microbiol Immunol 224:123, 1997
55. Galvin KM, Shi Y: Multiple mechanims of transcriptional repression by YY1. Moll Cell Biol 17:3723, 1997
56. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H: The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61:49, 1990
57. Desprez PY, Hara E, Bissell MJ, Campisi J: Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1. Mol Cell Biol 15:3398, 1995
58. Shoji W, Yamamoto T, Obinata M: The helix-loop-helix protein Id inhibits differentiation of murine erythroleukemia cells. J Biol Chem 269:5078, 1994
59. McCabe LR, Banerjee C, Kundu R, Harrison RJ, Dobner PR, Stein JL, Lian JB, Stein GS: Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: Role of Fra-2 and Jun D during differentiation. Endocrinology 137:4398, 1996
60. Upchurch GR, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF, Loscalzo J: Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272:17012, 1997
61. 2 act synergistically to enhance mitochondrial damage. J Biol Chem 273:30808, 1998
62. Rosenberg ME, Silkensen J: Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 27:633, 1995
63. Mackness B, Hunt R, Durrington PN, Mackness MI: Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis. Arterioscler Thromb Vase Biol 17:1233, 1997
64. Schwochau GB, Nath KA, Rosenberg ME: Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties. Kidney Int 53:1647, 1998
65. Wen ST, Van Etten RA: The PAG gene product, a stress-induced protein with antioxidant properties, is an Ab1 SH3-binding protein and a physiological inhibitor of c-Ab1 tyrosine kinase activity. Genes Dev 11:2456, 1997
66. Prosperi MT, Ferbus D, Rouillard D, Goubin G: The pag gene product, a physiological inhibitor of c-ab1 tyrosine kinase, is overexpressed in cells entering S phase and by contact with agents inducing oxidative stress. FEBS Lett 423:39, 1998
67. Siow RC, Ishii T, Sato H, Taketani S, Leake DS, Sweiry JH, Pearson JD, Bannai S, Mann GE: Induction of the antioxidant stress proteins heme oxygenase-1 and MSP23 by stress agents and oxidized LDL in cultured vascular smooth muscle cells. FEBS Lett 368:239, 1995
68. Toborek M, Kopieczna-Grzebieniak E, Drozdz M, Wieczorek M: Increased lipid peroxidation as a mechanism of methionine-induced atherosclerosis in rabbits. Atherosclerosis 115:217, 1995
69. 3 pituitary cell by perturbants of early protein processing that induce GRP78. J Biol Chem 267:16751, 1992
70. Duncan G, Wormstone IM, Liu CS, Marcantonio JM, Davies PD: Thapsigargin-coated intraocular lenses inhibit human lens cell growth. Nature Med 3:1026, 1997
71. Li XA, Lee AS: Competitive inhibition of a set of endoplasmic reticulum protein genes (GRP78, GRP94, and Erp72) retards cell growth and lowers viability after ionophore treatment. Mol Cell Biol 11:3446, 1991
72. George SJ, Johnson JL, Angelini GD, Jeremy JY: Short-term exposure to thapsigargin inhibits neointima formation in human saphenous vein. ArteriosclerThromb Vasc Biol 17:2500, 1997